. De novo ICAM-1 synthesis in the mouse lung: model of assessment of protein expression in lungs.
RECRUITMENT OF POLYMORPHONUCLEAR leukocytes (PMNs) to the site of infection is a complex process initiated by the binding between adhesive molecules on the endothelial cell surface and their ligands on the surface of leukocytes (13, 26, 28) . Intercellular adhesion molecule-1 (ICAM-1), an inducible endothelial counterreceptor for ␤ 2 -integrins (CD11/CD18), is crucial in mediating stable adhesion of PMNs to endothelial cells. Engagement of ICAM-1 by ␤ 2 -integrins enables PMNs to migrate across the endothelial barrier in the region of infection. Although ICAM-1 is constitutively expressed in endothelial cells, the regulation of its expression level by proinflammatory cytokines is a critical innate immune defense mechanism during infection, since increased ICAM-1 expression is essential for recruitment of PMNs. Tumor necrosis factor-␣ (TNF-␣), a proinflammatory cytokine, promotes adhesion of PMNs to vascular endothelium primarily by inducing the expression of ICAM-1 (5) . The transcription factor NF-B is a key regulator of ICAM-1 gene expression after TNF-␣ challenge of endothelial cells (14) . Recent studies have indicated that NF-B activation is regulated by NADPH oxidase-dependent pathways (22, 23) . NADPH oxidase is an enzyme assembled in endothelial cell membrane that produces superoxide anion (O 2 Ϫ ) via the reaction 2 O 2 ϩ NADPH 3 2 O 2 Ϫ ϩ NADP ϩ ϩ H ϩ (15) (16) (17) 25) . The fully functional NADPH oxidase enzyme is a protein complex composed of a membrane-bound flavocytochrome b 558 and its cytosolic activation factors Rac2, p40 phox , p47 phox , and p67 phox . The membrane-bound flavocytochrome b 558 consists of two heme redox centers and the subcomponents p22
phox and gp91 phox . The recruitment of cytoplasmic RhoGTPase Rac2, and p40 phox , p47 phox , and p67 phox , to the flavocytochrome b 558 membrane complex is considered the pivotal event in the activation of NADPH oxidase and subsequent generation of O 2 Ϫ (15) (16) (17) 25) . Oxidant signaling via NADPH oxidase is thought to regulate TNF-␣-induced NF-B activation in endothelial cells (8) . TNF-␣-induced activation of NF-B results in increased expression of ICAM-1 (6, 7, 16) . Because most of the studies addressing this regulatory mechanism have been done in cultured endothelial cells, we developed an isolated mouse lung preparation to study the expression of ICAM-1 gene and protein and its functional consequences in the proper cellular context of the organ. We also used mice genetically deficient in p47 phox to address the role of the NADPH oxidase complex in signaling of ICAM-1 expression. We demonstrate the value of assessing gene and protein expression in vascular endothelial cells of the isolated-perfused lung preparation. Our results show that the robust ICAM-1 expression observed in lung endothelia in situ is dependent on NADPH oxidase-derived oxidant signaling and NF-B activation.
MATERIALS AND METHODS

Materials
Reagents.
32 P was purchased from ICN Pharmaceuticals (Costa Mesa, CA). ICAM-1 polyclonal goat blocking antibody (Ab), goat anti-actin Ab, and goat anti-mouse horseradish peroxidase-linked IgG were obtained from Santa Cruz Biotechnology (Santa Cruz, CA). Mouse TNF-␣ was purchased from Cedarlane Laboratories (Ontario, Canada Mice were housed in pathogen-free conditions with free access to food and water at the University of Illinois Biological Resources Laboratory. All studies were made using approved institutional protocols conforming to institutional and NIH guidelines.
Methods
Mouse lung isolation and lung perfusion. Mice were anesthetized inside a bell jar using 3% halothane in room air, which was supplied at a flow rate of 2 l/min. With the animal lying in a supine position, anesthesia was continued by means of a nose cone. The trachea was cannulated with a 19-gauge stainless steel tube for constant positive pressure ventilation (pressure-controlled ventilator; Kent Scientific, Litchfield, CT) with the anesthetic gas mixture. Heparin (50 units) was injected in the jugular vein for anticoagulation. The abdominal cavity was opened to expose the diaphragm, which was ventrally punctured and cut free from the rib cage. A thoracotomy was performed, and the two halves of the rib cage were retracted to expose the heart and lungs. To make the pulmonary artery accessible for cannulation, the heart was caudally retracted with a silk suture (5-0; Ethicon, Somerville, NJ) through the apical musculature of the right ventricle. An incision was made in the right ventricle near the base of the pulmonary artery for introducing an arterial cannula. The cannula (PE-60) was maneuvered in the pulmonary artery via the pulmonic valve and secured by means of a suture encompassing the pulmonary artery and the underlying aorta. An incision was then made in the left atrium to insert a venous catheter (PE-60, with flared end) that was secured to the atrial appendage with 5-0 silk. The lungs were ventilated (120/min with end-expiratory pressure set at 2.0 cmH 2O) and perfused in situ (2 ml/min, 37°C) with the aid of a peristaltic pump (Gilson, Middleton, WI). Venous pressure was set to ϩ1 cmH2O. The perfusing liquid used was bicarbonate-buffered RPMI 1640 medium supplemented with 3 g/100 ml (3%) BSA. For control of solution pH, the lungs were ventilated with a gas mixture containing 20% O2 and 5% CO2 (balance 75% N2). Lung preparations were perfused for 20 min (i.e., the equilibration period). TNF-␣ was infused at of rate of 0.2 ml/min through a side port in the arterial cannula to achieve the final perfusate concentration of 2,000 U/ml. Experimental preparations received TNF-␣ for periods of 0, 0.5, 1, 2, or 3.5 h. Control preparations were treated identically except that TNF-␣ was excluded from the infusate. Stability of perfusate pH was verified at the end of all experiments; acceptable lung preparations had pH values of 7.35-7.45 in the venous effluent.
Oxidant generation by lung microvasculature. To measure oxidant production in pulmonary vessels, we used a fluorigenic reagent with up to 1,000 times greater sensitivity than conventional methods (4, 29) . OxyBurst Green (H2HFF-BSA) consists of BSA coupled to the reduced probe, dihydro-2Ј,4,5,6,7,7Ј-hexafluorofluorescein (H2HFF), which is not fluorescent. Mouse lungs were set up as described above. After a 20-min equilibration perfusion, 5 ml of albumin-Krebs solution containing the albumin-H2HFF conjugate (200 g/ml) were recirculated at a flow rate of 1 ml/min. Serial 50-l samples of perfusate were collected from the venous cannula at intervals of 8 min for a 60-min period. A test substance, e.g., TNF-␣, was added to the perfusate after three baseline samples had been drawn. Control preparations were treated identically except that TNF-␣ was omitted. All samples were transferred to tightly stoppered glass tubes under 100% nitrogen. The fluorescence intensity of the samples was measured immediately using a spectrofluorometer set to the excitation and emission maxima of the oxidized probe (488 and 530 nm, respectively).
Western blot analysis of ICAM-1 from mouse lung homogenates.
Control or TNF-␣-challenged mouse lung preparations (see Mouse lung isolation and lung perfusion) were quick-frozen with liquid nitrogen, and, with the aid of a tissue grinder, homogenized in PBS (pH 7.4) containing protease inhibitor cocktail (60 l/10 ml PBS; Sigma). The homogenates were centrifuged for 10 min at 14,000 revolutions/min (rpm) and 4°C. Supernatants were collected, and protein concentration of each sample was measured with a bicinchoninic acid assay kit using BSA as standard (Pierce, Rockford, IL). An equal amount of protein from each sample (125 g) was resolved in 10% Tris-glycine SDS polycrylalmine gel. Protein bands were blotted to nitrocellulose membranes (Millipore, Bedford, MA). After incubation for 1 h in blocking solution (5% dry milk in Tris-buffered saline with Tween 20) at room temperature, the membrane was incubated for 24 h with anti-ICAM-1 polyclonal Ab (1:2,000) at 4°C. The membrane was then incubated with secondary Ab (horseradish peroxidaseconjugated goat anti-mouse Ab at 1:1,000 dilution) for 1-2 h at room temperature. Peroxidase labeling was detected with the enhanced chemiluminescence Western blotting detection system (Amersham Biosciences, Piscataway, NJ).
Nuclear extract preparation and electrophoretic mobility shift assay. Control or TNF-␣-challenged mouse lungs (see Mouse lung isolation and lung perfusion) were minced in 0.5 ml of ice-cold buffer A consisting of (in mM) 10 HEPES (pH 7.9), 1.5 KCl, 10 MgCl 2, 0.5 dithiothreitol (DTT), and 0.5 phenylmethylsulfonyl fluoride (PMSF), plus 0.1 g/100 ml IGEPAL CA-630 (Sigma). The minced tissue was homogenized using a Dounce homogenizer. The crude nuclear pellet was incubated for 30 min on ice (28°C) and then centrifuged for 10 min at 14,000 rpm and 4°C. The resulting pellet was resuspended in 0.5 ml of buffer B containing (in mM) 20 HEPES (pH 7.9), 1.5 MgCl2, 420 NaCl, 0.5 DTT, 0.2 EDTA, 0.5 PMSF, and 4 leupeptin, plus 25 g/100 ml glycerol, and incubated at 28°C for 30 min. The suspension was centrifuged for 30 min at 14,000 rpm and 4°C. The supernatant (nuclear protein) was collected and stored at Ϫ80°C. Protein concentration was determined using a bicinchoninic acid assay kit with BSA as standard (Pierce). Electrophoretic mobility shift assays were performed as described (21) .
Recovery of vascular endothelial cells from mouse lung for immunofluorescence studies. Tissue from control or TNF-␣-challenged lungs was placed in a sterile petri dish and diced into small fragments (ϳ1 mm diameter) using surgical scissors. The lung fragments were transferred using a serological pipette to a sterile 15-ml centrifuge tube. A 10-ml solution of sterile, filtered collagenase A (1.75%; Roche, Indianapolis, IN) was added to each tube, and tubes were placed on a rocking shaker inside of a 37°C incubator for 30 min. The fragments were centrifuged at 1,000 g for 2 min at 22°C. The collagenase supernatant was removed and replaced with 4 ml of modified endothelial growth medium-2 (Cambrex, Baltimore, MD) supplemented with penicillin/streptomycin. The fragments were gently triturated two times using a serological pipette. Larger fragments were allowed to settle for ϳ2 s, and the supernatant containing cell clusters was immediately applied to gelatinized 1.5-cm glass cover slips in a 12-well dish. The islets were allowed 30 min to attach to the cover slip, gently washed with PBS, and then fixed with 3.7% formaldehyde in PBS for 20 min. The islets were permeabilized with 0.4% Triton X-100 in PBS. Cells were then blocked using 3% BSA plus 2% gelatin in Hanks' balanced salt solution for 20 min, followed by incubation for 1 h with primary antibodies against ICAM-1 (mouse, G-5) and VE-cadherin (goat, C-19; Santa Cruz), to identify endothelial cells, at a dilution of 1:100 in blocking buffer. The cover slips were washed three times in PBS, then blocked again for 20 min, followed by incubation with fluorescent secondary Abs (Donkey anti-mouse Alexa 594-and anti-goat Alexa 488-labeled Abs; Molecular Probes, Eugene, OR) at a dilution of 1:200 in blocking buffer. The cover slips were washed three times in PBS, mounted in ProLong Antifade Medium (Molecular Probes), and analyzed with a confocal microscope (Carl Zeiss LSM 510).
Statistical analysis. Data are expressed as means Ϯ SE. Comparisons between experimental groups were made by unpaired t-tests and ANOVA; post hoc comparisons among groups were made using the Neumann-Keuls test. The significance level was set at P Ͻ 0.05.
RESULTS
We carried out experiments using intact mouse lungs to address the role of TNF-␣ activation of the transcription factor NF-B in mediating the de novo synthesis of ICAM-1. Studies were made in the isolated-perfused lung model to assess ICAM-1 gene and protein expression in lung vascular endothelial cells in situ. Because this experimental strategy required stable lung preparations, we used an enriched perfusing solution (RPMI 1640) containing all 20 amino acids, which supported protein synthesis and extended the lifetime of lung preparations from ϳ1.5 h (9) to 4 h. The wet-to-dry ratio of six lung preparations perfused with RPMI medium for 4 h averaged 5.3 Ϯ 0.3, a value comparable to the ratios determined in Krebs-perfused mouse lung preparations maintained for Ͻ1 h ex vivo (27) .
The cytokine TNF-␣ activates NF-B in endothelial cells in culture secondary to oxidant generation by NADPH oxidase (3, 24) . We therefore evaluated the effects of TNF-␣ in perfused mouse lungs. We made serial measurements of oxidant release in the pulmonary venous effluent before (basal) and during a 30-min period in the absence (control group) or presence of TNF-␣ (2,000 U/ml) added to the perfusate. TNF-␣ produced an immediate rise in oxidized probe (see MATERIALS AND METH-ODS) recovered from perfusate, which continued to accumulate during the 30-min period (Fig. 1) . The control (untreated) lungs showed only background fluorescence. To address the basis of oxidants elicited by TNF-␣ challenge, we studied lungs obtained from p47 phoxϪ/Ϫ mice, which lack the functional NADPH oxidase. TNF-␣ was ineffective in p47 phoxϪ/Ϫ mice in inducing oxidant production, indicating that NADPH oxidase was the exclusive source of the detected oxidants.
We next addressed the role of oxidant signaling in lungs in mediating the activation of NF-B induced by TNF-␣. Figure  2A shows the activation of NF-B in the nuclear fraction of lung homogenates by gel-shift assay. TNF-␣ activated NF-B within 15 min, and the activation was pronounced at 30 min ( Fig. 2A, lane 2) . A low basal level of activation was observed in control unchallenged lungs (Fig. 2A, lane 1) . The effect of TNF-␣ was abrogated in lungs from p47 phoxϪ/Ϫ mice ( Fig. 2A,  lane 3) ; basal (unstimulated) NF-B activation was lower in the p47 phoxϪ/Ϫ mouse lung than the control, implying that NADPH oxidase was constitutively active in the wild-type lung. We quantified NF-B levels by densitometry (see Fig.  2A ); results are presented in Fig. 2B . TNF-␣ significantly increased the NF-B level in wild-type lungs, whereas this effect of TNF-␣ did not develop in lungs from p47 phoxϪ/Ϫ mice (Fig. 2B) .
We determined the time course of ICAM-1 expression after TNF-␣ challenge (0.5, 12, 2, and 3.5 h) in the mouse lungs in situ. Mean levels of ICAM-1 expression (based on densitometric analysis of Western blots) trended toward higher expression phoxϩ/ϩ ) and p47 phox -deficient (p47 phoxϪ/Ϫ ) mice as measured by the fluorescence of albumin-conjugated dihydro-2Ј,4,5,6,7,7Ј-hexafluorofluorescein (H2HFF) in perfused lungs. After lung isolation and equilibration for 20 min (see MATERIALS AND METHODS), preparations received the H2HFF-albumin conjugate (200 g/ml) in a 5-ml volume of perfusate, which was recirculated at 1 ml/min and 37°C. Serial 50-l samples of perfusate were taken from the venous cannula at intervals of 8 min for up to 1 h. The fluorescence intensity of the samples was measured using a spectrofluorometer set to excitation and emission maxima for oxidized probe (488 and 530 nm, respectively); reduced probe is nonfluorescent. TNF-␣ (2,000 U/ml, arrow) added to the perfusate produced an immediate increase in probe fluorescence because of generation of oxidants within lung vessels. This was not the case in lungs from p47 phoxϪ/Ϫ mice (triangles) lacking the ability to generate oxidants via NADPH oxidase. Time control experiments in normal mice (squares) showed that unstimulated preparations generate oxidants at a background level during the entire experimental period. *Significance with respect to corresponding time 0 value; error bars are SE (n ϭ 3 preparations/group). **Statistical difference from the wild-type control (without drug) and p47
phoxϪ/Ϫ lungs (with TNF-␣). levels between 1 and 3.5 h, but the 3.5-h value was significantly higher than basal (Fig. 3A) . Time-control experiments showed a low and constant expression level of ICAM-1 in untreated lungs from wild-type mice perfused for 3.5 h (Fig. 3B) .
Because ICAM-1 expression observed in lungs in situ reflects expression in multiple cell types, we carried out immunofluorescent staining to identify whether endothelial cells from these lungs were responsive to TNF-␣ in terms of increased ICAM-1 expression. The lung preparations received TNF-␣ for 3 h, and a collagenase digest of the lung was immediately prepared (see METHODS). The obtained cells were plated and stained for VE-cadherin, an endothelial cell marker. VE-cadherin-positive cells were seen as uniform cell clusters (green fluorescence; Fig. 4 ). The cells were counterstained for ICAM-1 (red fluorescence; Fig. 4) . TNF-␣ challenge of lungs caused a marked increase in ICAM-1 immunofluorescence only in the VE-cadherin-positive cells. ICAM-1 immunofluorescence was evident in the cell cytosol and perinuclear region in the majority of endothelial cells at 3 h after TNF-␣ challenge of lungs (Fig. 4) , consistent with de novo synthesis of ICAM-1.
DISCUSSION
The key observation made in the present study was the induction of de novo ICAM-1 protein expression by TNF-␣ in endothelial cells of the intact mouse lung preparation. We chose TNF-␣ for this study because it is a cytokine appearing in the circulation under conditions of acute inflammation and septic shock (1) and it is known to induce adhesiveness of the endothelium for leukocytes required for leukocyte extravasation by diapedesis (10, 22, 23) . Our understanding in molecular terms of the role of TNF-␣ in inducing expression of adhesion proteins is based primarily on in vitro studies utilizing vascular endothelial cell monolayers that exhibit NF-B-dependent regulation of ICAM-1 gene and protein expression accompanied by increased endothelial adhesivity and transendothelial migration of added PMNs (10, 22, 23) . Thus we used the perfused lung preparation to address the physiological significance of these observations. The lung preparation was advantageous by allowing use of cell-free perfusing liquid at constant temperature and flow, and lung isolation allowed assessment of direct pulmonary vascular effects of TNF-␣ without the complication of secondary effects of TNF-␣ on nonpulmonary organs and tissues (including blood cells). Moreover, the isolated lung method lends itself to a variety of rigorous physiological assessments not possible in vivo (e.g., vascular permeability and indium-labeled PMN binding to the vessel wall) and biochemical assays. In the present study, we measured oxidant generation, NF-B activity, and ICAM-1 protein expression under uniform experimental conditions, and, with the aid of suitable genetic mouse models, we established clearly the role of NADPH oxidase-derived oxidant generation in the regulation of ICAM-1 gene expression. Specifically, the blots in Fig.  2 demonstrate the important role of oxidants in regulating ICAM-1 gene expression at the level of the transcription factor NF-B, which was not activated in response to TNF-␣ in lungs obtained from p47 phoxϪ/Ϫ mice. Furthermore, our results demonstrate the absence of ICAM-1 expression in NADPH oxidase null lungs. By contrast, oxidant generation in wild-type lungs was immediate and persistent over the study period in response to TNF-␣, and NF-B activation was observed 15-30 min later. These results suggest that TNF-␣ sequentially activates NADPH oxidase and NF-B, thereby inducing de novo ICAM-1 expression in the lung vasculature. Oxidant signalingmediated activation of NF-B has been demonstrated in cultured endothelial cells (7, 23) . TNF-␣ induced ICAM-1 expression in endothelial cell monolayers within 2-4 h (12, 22) , which is in the range of ICAM-1 expression observed in the intact lung vascular bed in the present study.
A concern in the assessment of ICAM-1 expression in the intact lung is that the result may not be ascribed to the expression of protein in endothelial cells. Thus we isolated endothelial cells from lungs after TNF-␣ challenge (see METH-ODS). We used anti-VE-cadherin Ab and carried out immunostaining to identify the vascular endothelial cells. The isolated endothelial cells positive for VE-cadherin also showed robust expression of ICAM-1, indicating that endothelial cells were activated in situ after the TNF-␣ challenge.
The feasibility of the experiments depended on the development of the ex vivo mouse lung model, permitting us to extend its useful lifetime from ϳ1.5 to 4 h after isolation. This is an important consideration since significant de novo protein synthesis can occur in a time frame of Ͼ3 h, as seen with ICAM-1 protein expression. The key modification was use of an enriched perfusing liquid (RPMI 1640) containing albumin as osmotic balancer to replace albumin-Krebs solution. RPMI perfusion gave stable pulmonary arterial pressure without any sign of atelectasis or lung edema during the period of lung perfusion. The ex vivo mouse lung preparation has advantages for gene expression studies. First, the preparation can be used to assess the role of alterations in shear stress suggested to affect gene expression in cultured endothelial cells (2, 3) . Second, the role of protein expression and certain aspects of acute lung injury response can be investigated (e.g., ischemia, increase in PMN adhesion to the vessel wall, and increase in lung vascular permeability) during an ex vivo experiment. However, the important caveat is the need for a stable lung preparation capable of maintaining fluid balance, since development of lung edema may trigger proteolysis (18 -20) , which may then injure the subendothelial matrix and endothelial cells, and thus interfere with protein expression.
In conclusion, we have shown that TNF-␣ induces ICAM-1 protein expression in endothelial cells of the intact mouse lung. ICAM-1 expression required NADPH oxidase-dependent oxidant signaling and NF-B activation. These results also show the potential value of using this isogravimetric preparation for studies of gene and protein expression in lung endothelia.
